ClinConnect ClinConnect Logo
Search / Trial NCT05620407

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Launched by BRISTOL-MYERS SQUIBB · Nov 10, 2022

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Autoimmune Diseases Immune System Diseases Connective Tissue Diseases Immune Mediated Diseases Active Systemic Lupus Erythematosus Lupus Sle Deucravacitinib Tyk2 Poetyk Poetyk Sle

ClinConnect Summary

This clinical trial is studying a new medication called deucravacitinib to see how effective and safe it is for people with active systemic lupus erythematosus (SLE), a condition that can cause inflammation and damage in various parts of the body. The trial is looking for participants aged 18 to 75 who have been diagnosed with SLE for at least six months and have specific signs of disease activity. To join, participants must have been on stable background treatments for lupus for a certain period before the study.

Participants in this trial will receive either the new medication (deucravacitinib) or a placebo, which is a harmless pill that looks like the real drug but contains no active ingredients. Throughout the study, they will be closely monitored for any changes in their condition and for any side effects. This research is crucial because it may help improve treatments for SLE, which can be challenging to manage. It’s important to note that individuals with certain other health conditions or those taking specific medications may not be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Diagnosed with Systemic Lupus Erythematosus (SLE) at least 24 weeks before the screening visit.
  • Meet the European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for SLE.
  • One of the following: positive antinuclear antibodies (ANA) ≥ 1:80 at screening OR positive anti dsDNA OR positive anti Smith (anti Sm) as determined by the central laboratory at screening.
  • Total Systemic Lupus Erythematosus Disease Activity Index-2K (SLEDAI-2K) score ≥ 6 points and clinical SLEDAI 2K score ≥ 4 points with joint involvement, and/or cutaneous vasculitis, and/or rash.
  • Lupus headache, alopecia, organic brain syndrome, and mucosal ulcers must be recorded on SLEDAI 2K, if indicated, but do not count toward the points required for screening at entry.
  • At least one SLE background therapy(immunosuppressant and/or antimalarial) is required for ≥ 12 weeks before the screening visit, must be at a stable dose for ≥ 8 weeks before the screening visit, and must remain stable until randomization and throughout study participation.
  • Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable for ≥ 2 weeks before the screening visit, cannot exceed 30 mg/day at screening, and must remain stable until the Week 4 visit. Participants can be on an OCS as well as an antimalarial and/or an immunosuppressant.
  • Exclusion Criteria
  • Diagnosis of drug-induced SLE rather than idiopathic SLE.
  • Other autoimmune diseases (eg, multiple sclerosis, psoriasis, inflammatory bowel disease, etc.) are excluded. Participants with type I autoimmune diabetes mellitus, thyroid autoimmune disease, Celiac disease, or secondary Sjögren's syndrome are not excluded -SLE overlap syndromes including, but not limited to, rheumatoid arthritis, scleroderma, and mixed connective tissue disease are excluded.
  • Active or unstable lupus neuropsychiatric manifestations, including, but not limited to, any condition defined by BILAG A criteria.
  • Active, severe Class III, and IV, lupus nephritis that requires or may require treatment with cytotoxic agents or high-dose CS.
  • History of congenital or acquired immunodeficiency.
  • Known active infection, or any major episode of infection requiring hospitalization or treatment with parenteral (intramuscular or IV) antimicrobial agents (eg, antibiotics antiviral, antifungal, or antiparasitic agents) within 30 days of randomization, or treatment with oral antimicrobial agents within 2 weeks of randomization -Currently on any therapy for chronic infection (eg, pneumocystis, herpes zoster, cytomegalovirus, invasive bacterial or fungal infections, or atypical mycobacteria).
  • Taking more than 1 immunosuppressant at screening.
  • In Japan only: Participants with positive result of β - D-glucan assay.
  • Other protocol-defined Inclusion/Exclusion criteria apply.

About Bristol Myers Squibb

Bristol-Myers Squibb (BMS) is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. With a robust portfolio of products across multiple therapeutic areas, including oncology, immunology, cardiovascular, and fibrotic diseases, BMS emphasizes cutting-edge research and a commitment to advancing medical science through clinical trials. The company is driven by a mission to provide transformative therapies, leveraging collaboration and scientific expertise to address unmet medical needs and improve patient outcomes worldwide.

Locations

Ann Arbor, Michigan, United States

Boston, Massachusetts, United States

New York, New York, United States

New York, New York, United States

Oklahoma City, Oklahoma, United States

Charleston, South Carolina, United States

Boston, Massachusetts, United States

Liverpool, New South Wales, Australia

Philadelphia, Pennsylvania, United States

Sapporo, Hokkaido, Japan

Syracuse, New York, United States

Singapore, , Singapore

Ridgewood, New Jersey, United States

Cincinnati, Ohio, United States

Wheaton, Maryland, United States

Tokyo, , Japan

Santander, Cantabria, Spain

Fukuoka, , Japan

Okayama, , Japan

Taipei, , Taiwan

Tokyo, , Japan

Taichung, , Taiwan

Porto Alegre, Rio Grande Do Sul, Brazil

Dallas, Texas, United States

Jackson, Tennessee, United States

Praha 2, , Czechia

Barcelona, , Spain

Nagoya, Aichi, Japan

Nagasaki, , Japan

La Plata, Buenos Aires, Argentina

Fukushima, , Japan

Niigata, , Japan

Cleveland, Ohio, United States

Oaxaca, , Mexico

Sapporo, Hokkaido, Japan

Taipei, , Taiwan

Sagamihara, Kanagawa, Japan

Valladolid, , Spain

Santander, Cantabria, Spain

Austin, Texas, United States

Santiago, , Chile

Kawagoe, Saitama, Japan

Gifu, , Japan

Pilar, Buenos Aires, Argentina

Maroochydore, Queensland, Australia

London, Greater London, United Kingdom

Mérida, Badajoz, Spain

Sendai Shi, Miyagi, Japan

Victoria Park, Western Australia, Australia

Szeged, Csongrád, Hungary

Kitakyushu, Fukuoka, Japan

Yokohama, Kanagawa, Japan

Lisbon, , Portugal

San Juan, , Puerto Rico

Sevilla, , Spain

London, , United Kingdom

Florencio Varela, Buenos Aires, Argentina

Bangkok, Krung Thep Maha Nakhon, Thailand

Wakayama, , Japan

Porto Alegre, Rio Grande Do Sul, Brazil

Danville, Virginia, United States

Veszprem, , Hungary

Brooklyn, New York, United States

Lajeado, Rio Grande Do Sul, Brazil

Athens, , Greece

Wroclaw, , Poland

Osaka, , Japan

Toyoake, Aichi, Japan

Houston, Texas, United States

Szeged, , Hungary

Nagpur, Maharashtra, India

Rochester, Minnesota, United States

València, , Spain

Temple, Texas, United States

Chiba, , Japan

Clearwater, Florida, United States

San M. De Tucuman, Tucumán, Argentina

Bunkyō, Tokyo, Japan

Veszprem, Veszprém City, Hungary

Torreon, Coahuila, Mexico

Margate, Florida, United States

Vellore, Tamil Nadu, India

Oxford, , United Kingdom

Antalya, , Turkey

San Francisco, California, United States

Marietta, Georgia, United States

San Leandro, California, United States

Ostrava, , Czechia

Bilbo, País Vasco, Spain

Nagoya, Aichi, Japan

Shimotsuga, Tochigi, Japan

Lodz, , Poland

Katy, Texas, United States

Grand Blanc, Michigan, United States

El Paso, Texas, United States

São Paulo, , Brazil

Ostrava, Ostrava Město, Czechia

Hubli, Karnataka, India

Santiago, , Chile

Taichung, , Taiwan

São Paulo, , Brazil

Barretos, São Paulo, Brazil

Atlanta, Georgia, United States

Vitória, Espírito Santo, Brazil

Pécs, Baranya, Hungary

Mysore, Karnataka, India

Pergamino, Buenos Aires, Argentina

Torreón, Coahuila, Mexico

Warszawa, , Poland

Orland Park, Illinois, United States

Maroochydore, Queensland, Australia

Barcelona, Barcelona [Barcelona], Spain

Worcester, Massachusetts, United States

London, London, City Of, United Kingdom

Taichung City, Taichung, Taiwan

Kita, Kagawa, Japan

Mexico City, Distrito Federal, Mexico

Zapopan, Jalisco, Mexico

Grand Blanc, Michigan, United States

Bothell, Washington, United States

Athens, Attikí, Greece

Skokie, Illinois, United States

Lisbon, Lisboa, Portugal

Sao Bernardo Do Campo, São Paulo, Brazil

São Paulo, , Brazil

Elbląg, Warmińsko Mazurskie, Poland

Cuernavaca, Morelos, Mexico

Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

Rio De Janeiro, , Brazil

Saint Louis, Missouri, United States

Warszawa, Mazowieckie, Poland

Paramatta, New South Wales, Australia

La Jolla, California, United States

Lisbon, , Portugal

Jacksonville, Florida, United States

Pergamino, Buenos Aires, Argentina

San Miguel De Tucumán, Tucumán, Argentina

La Plata, , Argentina

Curitiba, Paraná, Brazil

Santo André, São Paulo, Brazil

Sao Bernardo Do Campo, São Paulo, Brazil

Rio De Janeiro, , Brazil

Valdivia, Los Ríos, Chile

Santiago, Región Metropolitana De Santiago, Chile

Santiago, Región Metropolitana De Santiago, Chile

Santiago, Región Metropolitana De Santiago, Chile

Praha 2, , Czechia

Athens, Attikí, Greece

Pécs, Baranya, Hungary

Gyula, Békés, Hungary

Veszprem, Veszprém City, Hungary

Nagoya, Aichi, Japan

Eiheiji Cho,Yoshida Gun, Fukui, Japan

Asahikawa, Hokkaido, Japan

Sapporo, Hokkaido, Japan

Sagamihara, Kanagawa, Japan

Sasebo, Nagasaki, Japan

Bunkyo Ku, Tokyo, Japan

Itabashiku, Tokyo, Japan

Meguro Ku, Tokyo, Japan

Shinjyuku Ku, Tokyo, Japan

Chiba, , Japan

Fukushima, , Japan

Okayama, , Japan

Osaka, , Japan

Tokyo, , Japan

Tokyo, , Japan

Tokyo, , Japan

Torreon, Coahuila, Mexico

Mexico City, Distrito Federal, Mexico

Guadalajara, Jalisco, Mexico

Chihuahua, , Mexico

Chihuahua, , Mexico

Oaxaca, , Mexico

Lima, , Peru

Lima, , Peru

Lima, , Peru

Warszawa, Mazowieckie, Poland

Szczecin, Zachodniopomorskie, Poland

Warszawa, , Poland

Wroclaw, , Poland

Wroclaw, , Poland

Lodz, łódzkie, Poland

Lisbon, Lisboa, Portugal

Vila Nova De Gaia, Porto, Portugal

Barcelona, Barcelona [Barcelona], Spain

Santander, Cantabria, Spain

Sabadell, Catalunya [Cataluña], Spain

Cordoba, Córdoba, Spain

Bilbo, País Vasco, Spain

Vitoria Gasteiz, País Vasco, Spain

Sevilla, , Spain

Valladolid, , Spain

València, , Spain

Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

Taichung City, Taichung, Taiwan

Taichung, , Taiwan

Taichung, , Taiwan

Tainan City, , Taiwan

London, London, City Of, United Kingdom

London, London, City Of, United Kingdom

Cannock, Staffordshire, United Kingdom

Bradford, , United Kingdom

London, London, City Of, United Kingdom

Charlotte, North Carolina, United States

Pompano Beach, Florida, United States

Cuernavaca, Morelos, Mexico

Santa Monica, California, United States

Decatur, Georgia, United States

Colleyville, Texas, United States

Ciudad De Buenos Aires, Buenos Aires, Argentina

Florencio Varela, Buenos Aires, Argentina

Pilar, Buenos Aires, Argentina

San Miguel, Buenos Aires, Argentina

Quilmes, Ciudad Autónoma De Buenos Aires, Argentina

San M. De Tucuman, Tucumán, Argentina

San Juan, , Argentina

Victoria Park, Western Australia, Australia

Lajeado, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

São Paulo, , Brazil

La Serena, Coquimbo, Chile

Santiago, Región Metropolitana De Santiago, Chile

Santiago, Región Metropolitana De Santiago, Chile

Athens, Attikí (Region), Greece

Larissa, Thessalía, Greece

Szeged, Csongrád, Hungary

Kitakyushu, Fukuoka, Japan

Sendai Shi, Miyagi, Japan

Kawagoe, Saitama, Japan

Nagasaki, , Japan

Niigata, , Japan

Wakayama, , Japan

Cdmx, Distrito Federal, Mexico

Mexico City, Distrito Federal, Mexico

Leon, Guanajuato, Mexico

Zapopan, Jalisco, Mexico

Monterrey, Nuevo León, Mexico

Lima, , Peru

Krakow, Małopolskie, Poland

Elbląg, Warmińsko Mazurskie, Poland

Poznan, Wielkopolskie, Poland

ód, łódzkie, Poland

Lisbon, , Portugal

Singapore, , Singapore

Singapore, , Singapore

Mérida, Badajoz, Spain

Cordoba, Madrid, Spain

Taipei, , Taiwan

London, , United Kingdom

Oxford, , United Kingdom

Santiago, , Chile

Nagoya, Aichi, Japan

Toyoake, Aichi, Japan

Asahikawa, Hokkaido, Japan

Vitória, Espírito Santo, Brazil

São Paulo, , Brazil

Yokohama, Kanagawa, Japan

Kraków, , Poland

Kita, Kagawa, Japan

Sasebo, Nagasaki, Japan

Hollywood, Florida, United States

Gifu, , Japan

Antalya, , Turkey

Bunkyo Ku, Tokyo, Japan

Central Middlesbrough, Middlesbrough, United Kingdom

Brooklyn, New York, United States

Istanbul, , Turkey

Shimotsuga, Tochigi, Japan

Bunkyō, Tokyo, Japan

Meguro Ku, Tokyo, Japan

Ostrava, Ostrava Město, Czechia

Río Cuarto, , Argentina

Barretos, São Paulo, Brazil

Itabashi Ku, Tokyo, Japan

Lima, , Peru

Taipei, , Taiwan

San Miguel, Buenos Aires, Argentina

Plovdiv, , Bulgaria

Ruse, , Bulgaria

Sofia, , Bulgaria

Altindağ, Ankara, Turkey

Charlotte, North Carolina, United States

Lublin, Lubelskie, Poland

Warszawa, Mazowieckie, Poland

Lodz, łódzkie, Poland

Paramatta, New South Wales, Australia

Ivanhoe, Victoria, Australia

Shinjyuku Ku, Tokyo, Japan

Quilmes, Ciudad Autónoma De Buenos Aires, Argentina

Jacksonville, Florida, United States

Liverpool, New South Wales, Australia

Guadajalara, Jalisco, Mexico

Singapore, Central Singapore, Singapore

Santiago, Región Metropolitana De Santiago, Chile

Gaziantep, , Turkey

La Plata, Buenos Aires, Argentina

São Paulo, , Brazil

Curitiba, , Brazil

Ciudad De México, Distrito Federal, Mexico

Tainan City, , Taiwan

New Delhi, Delhi, India

Hubli, Karnataka, India

Hyderabad, Telangana, India

Ankara, , Turkey

Pittsburgh, Pennsylvania, United States

Vellore, Tamil Nadu, India

Las Vegas, Nevada, United States

Santiago, Región Metropolitana De Santiago, Chile

Leon, Guanajuato, Mexico

Guadalajara, Jalisco, Mexico

Warszawa, Mazowieckie, Poland

Szczecin, , Poland

Central Middlesbrough, Middlesbrough, United Kingdom

San Miguel De Tucumán, Tucumán, Argentina

Bangkok, Krung Thep Maha Nakhon, Thailand

Katy, Texas, United States

Santiago, Región Metropolitana De Santiago, Chile

Santiago, Región Metropolitana De Santiago, Chile

Monterrey, Nuevo León, Mexico

Lima, , Peru

Santiago, Región Metropolitana De Santiago, Chile

Lublin, Lubelskie, Poland

Warszawa, Mazowieckie, Poland

Lodz, łódzkie, Poland

Ciudad De Buenos Aires, Buenos Aires, Argentina

Ivanhoe, Victoria, Australia

Ruse, , Bulgaria

La Serena, Coquimbo, Chile

Ciudad De México, Distrito Federal, Mexico

Chihuahua, , Mexico

Poznan, Wielkopolskie, Poland

Plovdiv, , Bulgaria

Pompano Beach, Florida, United States

Sofia, , Bulgaria

Athens, Attikí (Region), Greece

Larissa, Thessalía, Greece

Ahmedabad, Gujarat, India

Vellore, Tamil Nadu, India

Kraków, Małopolskie, Poland

Bila Nova De Gaia, , Portugal

Bangkok, Krung Thep Maha Nakhon, Thailand

Bangkok, Krung Thep Maha Nakhon, Thailand

Gyula, Békés, Hungary

Clearwater, Florida, United States

Sofia, , Bulgaria

Santiago, Región Metropolitana De Santiago, Chile

Asahikawa, Hokkaido, Japan

Lima, , Peru

Toyoma, Toyama, Japan

Bunkyo Ku, Tokyo, Japan

Bunkyo Ku, Tokyo, Japan

Paramus, New Jersey, United States

Santiago, Región Metropolitana De Santiago, Chile

Mexico City, Distrito Federal, Mexico

Guadajalara, Jalisco, Mexico

Monterrey, Nuevo Leon, Mexico

Las Vegas, Nevada, United States

Paramus, New Jersey, United States

London, Greater London, United Kingdom

Sasebo, Nagasaki, Japan

Great Neck, New York, United States

Warszawa, Mazowieckie, Poland

Meguro Ku, Tokyo, Japan

Colleyville, Texas, United States

Sofia, Sofia (Stolitsa), Bulgaria

Santiago, Región Metropolitana De Santiago, Chile

Santiago, Región Metropolitana De Santiago, Chile

Mysore, Karnataka, India

Lima, , Peru

Wroclaw, Dolnośląskie, Poland

Chorzów, śląskie, Poland

London, England, United Kingdom

London, England, United Kingdom

Orland Park, Illinois, United States

Skokie, Illinois, United States

Las Vegas, Nevada, United States

Lima, , Peru

Cordoba, Madrid, Spain

Gaziantep, , Turkey

Charlotte, North Carolina, United States

Toyoma, Toyama, Japan

Lima, , Peru

Katy, Texas, United States

Fukuoka, , Japan

Bangkok, Krung Thep Maha Nakhon, Thailand

Great Neck, New York, United States

Porto Alegre, Rio Grande Do Sul, Brazil

Chorzów, śląskie, Poland

Florence, South Carolina, United States

Florence, South Carolina, United States

Secundarabad, Telangana, India

Florence, South Carolina, United States

Nagpur, Maharashtra, India

Secundarabad, Telangana, India

Porto Alegre, Rio Grande Do Sul, Brazil

San Miguel De Tucumán, Tucumán, Argentina

Porto Velho, Rondônia, Brazil

San Miguel, Buenos Aires, Argentina

Delray Beach, Florida, United States

New Orleans, Louisiana, United States

Recife, Pernambuco, Brazil

Ahmedabad, Gujarat, India

Lisbon, , Portugal

San M. De Tucuman, , Argentina

Quilmes, , Argentina

Barretos, , Brazil

Bilbo, , Spain

Sao Bernardo Do Campo, , Brazil

Vitória, , Brazil

Athens, , Greece

San Miguel De Tucumán, , Argentina

Porto Velho, , Brazil

Santo André, , Brazil

Sofia, , Bulgaria

Valdivia, , Chile

Santiago, , Chile

Santiago, , Chile

Santiago, , Chile

Santiago, , Chile

Santiago, , Chile

Larissa, , Greece

Gyula, , Hungary

Wroclaw, , Poland

Elbląg, , Poland

Chorzów, , Poland

Vitoria Gasteiz, , Spain

Searcy, Arkansas, United States

Ahmedabad, Gujarat, India

Ahmedabad, Gujarat, India

Hyderabad, Telangana, India

Vila Nova De Gaia, Porto, Portugal

Larbert, Falkirk, United Kingdom

San Diego, California, United States

Plant City, Florida, United States

Charleston, South Carolina, United States

Porto Velho, , Brazil

Caguas, , Puerto Rico

Patients applied

0 patients applied

Trial Officials

Bristol-Myers Squibb

Study Director

Bristol-Myers Squibb

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials